Baird Financial Group
GILD icon

Baird Financial Group’s Gilead Sciences GILD Stock Holding History

Baird Financial Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$39.3M Buy
282,089
+6,771
+2% +$948K 0.06% 208
2025
Q4 		$33.8M Buy
275,318
+82,788
+43% +$10.1M 0.05% 240
2025
Q3 		$21.4M Buy
192,530
+22,105
+13% +$2.51M 0.03% 362
2025
Q2 		$18.9M Sell
170,425
-8,323
-5% -$886K 0.03% 375
2025
Q1 		$20M Sell
178,748
-61,294
-26% -$6.32M 0.04% 353
2024
Q4 		$22.2M Sell
240,042
-14,715
-6% -$1.32M 0.04% 326
2024
Q3 		$21.4M Sell
254,757
-10,681
-4% -$815K 0.04% 326
2024
Q2 		$18.2M Buy
265,438
+69,495
+35% +$4.64M 0.04% 344
2024
Q1 		$14.4M Sell
195,943
-61,332
-24% -$4.72M 0.03% 399
2023
Q4 		$20.8M Sell
257,275
-25,350
-9% -$1.97M 0.05% 312
2023
Q3 		$21.2M Sell
282,625
-131,195
-32% -$10.1M 0.06% 276
2023
Q2 		$31.9M Buy
413,820
+141,571
+52% +$11.3M 0.08% 220
2023
Q1 		$22.6M Buy
272,249
+20,442
+8% +$1.69M 0.06% 284
2022
Q4 		$21.6M Sell
251,807
-46,009
-15% -$3.64M 0.06% 287
2022
Q3 		$18.4M Sell
297,816
-5,049
-2% -$318K 0.05% 300
2022
Q2 		$18.7M Sell
302,865
-145,544
-32% -$9.01M 0.05% 316
2022
Q1 		$26.7M Buy
448,409
+16,643
+4% +$1.06M 0.07% 267
2021
Q4 		$31.4M Sell
431,766
-189,988
-31% -$13.1M 0.07% 245
2021
Q3 		$43.4M Sell
621,754
-12,743
-2% -$895K 0.11% 197
2021
Q2 		$43.7M Sell
634,497
-819
-0.1% -$54.7K 0.11% 203
2021
Q1 		$41.1M Buy
635,316
+42,229
+7% +$2.72M 0.12% 200
2020
Q4 		$34.6M Sell
593,087
-33,943
-5% -$2.05M 0.1% 215
2020
Q3 		$39.6M Buy
627,030
+43,078
+7% +$2.99M 0.14% 180
2020
Q2 		$44.9M Buy
583,952
+114,464
+24% +$8.77M 0.17% 156
2020
Q1 		$35.1M Sell
469,488
-45,791
-9% -$3.16M 0.16% 161
2019
Q4 		$33.5M Sell
515,279
-240,273
-32% -$15.6M 0.12% 201
2019
Q3 		$47.9M Buy
755,552
+21,047
+3% +$1.38M 0.19% 142
2019
Q2 		$49.6M Sell
734,505
-36,286
-5% -$2.39M 0.19% 133
2019
Q1 		$50.1M Buy
770,791
+201,495
+35% +$13.4M 0.29% 99
2018
Q4 		$35.6M Buy
569,296
+129,194
+29% +$9.03M 0.24% 118
2018
Q3 		$34.3M Sell
440,102
-23,794
-5% -$1.8M 0.22% 134
2018
Q2 		$32.9M Sell
463,896
-15,041
-3% -$1.06M 0.22% 131
2018
Q1 		$36.1M Buy
478,937
+37,545
+9% +$2.98M 0.25% 121
2017
Q4 		$31.6M Sell
441,392
-13,268
-3% -$1.01M 0.22% 133
2017
Q3 		$36.8M Sell
454,660
-277,746
-38% -$21.2M 0.28% 112
2017
Q2 		$51.8M Buy
732,406
+110,512
+18% +$7.35M 0.41% 54
2017
Q1 		$42.2M Buy
621,894
+292,671
+89% +$20.6M 0.34% 79
2016
Q4 		$23.6M Sell
329,223
-52,742
-14% -$3.92M 0.2% 145
2016
Q3 		$30.2M Buy
381,965
+19,628
+5% +$1.59M 0.27% 105
2016
Q2 		$30.4M Buy
362,337
+47,709
+15% +$4.23M 0.28% 102
2016
Q1 		$28.9M Buy
314,628
+97
+0% +$8.75K 0.28% 106
2015
Q4 		$31.8M Buy
314,531
+27,213
+9% +$2.83M 0.32% 88
2015
Q3 		$28.2M Buy
287,318
+47,028
+20% +$5.22M 0.3% 96
2015
Q2 		$28.1M Buy
+240,290
New +$26.3M 0.28% 112

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Baird Financial Group's GILD Position: Q1 2026 in Review

Baird Financial Group increased its Gilead Sciences (GILD) stake by 2.5% in Q1 2026, buying an estimated $948K and bringing the position to 282,089 shares worth $39.3M. The position accounts for 0.06% of the portfolio, ranked #208.

Baird Financial Group first reported a position in GILD in Q2 2015 and has held it in 44 quarters since. The position peaked at $51.8M in Q2 2017. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Baird Financial Group held 282,089 shares of Gilead Sciences worth $39.3M as of Q1 2026.
  • Baird Financial Group bought 6,771 Gilead Sciences shares in Q1 2026, an estimated $948K.
  • Gilead Sciences made up 0.06% of Baird Financial Group's portfolio in Q1 2026, its #208 holding.
  • Baird Financial Group first reported a position in Gilead Sciences in Q2 2015 and has held it in 44 quarters since.
  • Baird Financial Group's Gilead Sciences position peaked at $51.8M in Q2 2017.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Baird Financial Group's 13F filing for Q1 2026, filed 14 May 2026.